Clinical isolates of Escherichia coli were examined for the presence of hydroxamate siderophore (aerobactin). The incidence of aerobactin-positive strains of E. coli from the blood was greater than the incidence of these strains isolated from other sites. The presence of aerobactin and the virulence of strains of E. coli in urinary tract infection were also examined in mice. The presence of aerobactin in the strains of E. coli correlated with virulence as measured by proportion of deaths but not with renal infection. These results suggest that the presence of aerobactin may be a significant factor in the invasion of the blood stream.
Iron compounds are known to enhance the growth of bacteria, including Escherichia coli. These nutrients must be obtained from the environment, where iron is usually present in an insoluble form or bound to an organic ligand. Bacteria have transport systems to obtain iron under these conditions. In E. coli, two iron-chelating substances, or siderophores, have been described: the catechol enterobactin (enterochelin) (12) and hydroxamate (aerobactin). Rogers (14) and other workers (7, 13) have postulated that the adequate production of siderophores by E. coli in vivo may be necessary for the virulence of certain microbes. Williams and Warner (18) showed that the E. coli mutants with aerobactin-type siderophores were more virulent than mutants without these siderophores. In the present study, we examined the frequency with which aerobactin is found in clinical isolates of E. coli. We also examined the relation of aerobactin to the virulence of E. coli in the pathogenesis of urinary tract infection and pyelonephritis in mice.
MATERIALS AND METHODS Bacteria. Clinical isolates of E. coli were obtained from patients at Rancho Los Amigos Hospital, Downey, Calif.
Blood isolates. Blood isolates were from 15 patients with liver disease, 8 patients with spinal cord injury, 3 patients with diabetes mellitus, and 6 patients with other diseases. These bacteremias were associated with urinary tract infection (16 patients), spontaneous bacterial peritonitis (7 patients) and other infections (2 patients). Seven patients with liver disease had bacteremia without an identifiable source.
Ascites isolates. The 30 E. coli strains isolated from ascites were all associated with spontaneous bacterial peritonitis in patients with liver disease.
Urine isolates. Sixteen urine isolates were from patients with neurogenic bladders and significant bacteriuria. None of these patients had bacteremia.
Laboratory strains. Twenty additional strains of E. coli (called laboratory strains) had been previously examined in a murine model, and their virulence in renal infection has been previously described (6) . Only 13 of these original 20 strains were available for study. These E. coli strains, which have * Corresponding author.
been described previously (6) , were stored lyophilized. Most of the strains had been maintained and used in in vitro studies in different laboratories. Their clinical sources are not known.
Rectal isolates. Nineteen rectal isolates of E. coli were obtained from hospital personnel at the same hospital.
Detection of aerobactin-producing strains. The strains of E. coli were cultured in minimal medium (Tris-succinate). The presence of hydroxamate was detected by the ferric perchlorate reaction (1) . In addition, a bioassay for aerobactin was performed with E. coli LG1522 (obtained from Peter H. Williams). This aerobactin-requiring strain was used as a lawn in an agar plate containing 0.2 mM a,oa' dipyridyl. A cell supernatant of each strain was added to a disk on the agar plate, and a halo of growth around the disk indicated the presence of aerobactin in the strain.
Survival of E. coli in serum. The survival of 55 E. coli strains in serum was examined as follows. Serum was obtained from a normal subject and frozen in small portions at -70°C within 2 hours. Overnight cultures of E. coli diluted in phosphate-buffered saline were added to inactivated serum (serum heated to 56°C for 30 min) to produce a final concentration of ca. 103 bacteria per ml and incubated for 24 h at 37°C. The number of E. coli cells surviving after incubation was determined by inoculation of serial dilutions of the mixture into molten nutrient agar.
Renal infection in mice. In a previous study, we examined a number of virulence factors of E. coli in a murine model of renal infection (6) . Ascending pyelonephritis had been produced by injecting E. coli cells into the exposed bladders of mice undergoing diuresis. Two measures were used to compare virulence: the ability of E. coli cells to produce renal infection (number of E. coli cells per gram of kidney), and the lethality of the infection produced by the E. coli. Deaths after infection with E. coli occurred in the first few days; the majority occurred within 24 hours. The percent mortality ranged from 0 to 79.6%. In that study, these measures of virulence were used to examine a number of bacterial factors that might influence virulence, including resistance to phagocytosis by polymorphonuclear leukocytes, growth in minimal medium and urine, presence of K antigen, resistance to serum bactericidal activity, dulcitol fermentation, rough mutation, and motility (6) . In other studies, we have examined the adherence of these E. coli to bladder epithelial cells (11) and enterobactin production by the E. coli (10) .
Statistical analysis. The incidence of aerobactin-positive strains of E. coli isolated from different sites was compared by chi-square analysis.
In the murine model, the relation of the aerobactin-production to renal infection, proportion of deaths, growth in urine and minimal medium, serum bactericidal activity, resistance to phagocytosis, epithelial adherence, and enterobactin was examined by comparing these factors in aerobactin-positive and -negative strains with Student's t tests. To determine whether aerobactin correlated with K antigen, dulcitol fermentation, motility, and rough mutation, we compared the incidence of each of these factors in aerobactin-positive and -negative strains with the Fisher exact test.
RESULTS
The incidence of aerobactin-positive strains from the various sites of infection is shown in Table 1 . The incidence of aerobactin-positive strains of E. coli from the blood (75%) was significantly higher than the incidence of these strains from other sites (38 to 47%). When the incidence of aerobactin-positive strains in blood isolates was compared with the incidence of aerobactin-positive E. coli from all other sites, the difference became more significant (P = 0.004).
In the murine model, the mean proportion of deaths in aerobactin-positive E. coli was significantly greater than the proportion of deaths in aerobactin-negative strains (Table 2) . There were more renal infections with the aerobactin-positive strains, but the difference was not significant. Table 3 shows the results of comparing a number of measures of host-parasite interaction in aerobactin-positive and -negative strains. There was a strong correlation of aerobactin with the growth of the strains in urine (Table 3) . Urine was obtained from mice undergoing diuresis and from mice without diuresis, and this same urine was diluted. The correlation was only with the urine from the mice that were diuresing or with the diluted urine. The resistance of these strains of E. coli to a pool of normal human serum was also examined. There was no correlation between aerobactin production and serum resistance.
E. coli strains showed a weak correlation between aerobactin production and resistance to phagocytosis and the presence of K antigen. There was no correlation with enterobactin, dulcitol fermentation, or adherence in epithelial cells. In this murine model, the aerobactin siderophore was more significant than enterobactin ( Table 4 ). The presence of aerobactin correlated with deaths of mice and growth of strains in urine, with some questionable significance for K antigen presence and phagocytosis resistance. Enterobactin only correlated with the rough mutation and serum sensitivity.
The growth of E. coli in inactivated normal human serum is shown in Table 5 . Aerobactin-positive strains survived better in inactivated serum than aerobactin-negative strains (P < 0.01).
DISCUSSION
There are numerous studies indicating that infections may be enhanced by iron, and there are many suggested mechanisms by which iron may influence host-parasite interaction (2, 4, 17) . Iron compounds increase the growth of bacteria, including E. coli in vitro and in vivo (3). Parenteral iron has been shown to enhance various experimental infections, including pyelonephritis (5, 17) . It has been suggested that human serum may be bactericidal or bacteriostatic because of the presence of iron-binding proteins (transferrins) in the serum which reduce the availability of iron to bacteria (15, 17) . It has also been postulated that bacteria which can multiply in mammalian serum may possess iron-binding siderophores which remove iron from transferrin complexes in the serum (7, 13, 14 The bowel is the probable reservoir of E. coli for human infection, and an alternative explanation for our results might be that patients with bacteremia had more aerobactinpositive strains in the stool than patients with other infections. Further studies will be necessary to resolve this question.
Isolates of E. coli from ascites were from patients with spontaneous bacterial peritonitis. Since this infection probably follows bacteremia, it is surprising that a greater proportion of these strains were not aerobactin positive. It is possible that patients with liver disease have altered host defenses as a result of changes in iron metabolism. Some indication that this is so is seen in the incidence of aerobactin-positive E. coli in bacteremic patients with liver disease. Of 15 bacteremic patients with liver disease, 9 had E. coli that were aerobactin positive. Of 17 E. coli isolated from patients with bacteremia associated with other diseases, 15 were aerobactin positive. In mice, the aerobactin-positive strains were associated with a higher proportion of early deaths which were probably the result of bacteremia. We previously examined the siderophore enterobactin, which did not correlate with virulence in E. coli in the development of renal infection or the proportion of deaths (10). Miles and Khimji (9) were also unable to show a relationship between enterobactin production and virulence in E. coli. Our results suggest that aerobactin may be a more significant factor than enterobactin in bacteremia in mice. All wild-type E. coli produce enterobactin, and the aerobactin siderophore may confer advantage on E. coli strains that also synthesize enterobactin. Konopka et al. (8) found that in serum, aerobactin had a greater ability than enterobactin to sequester iron from transferrin.
In the present experiments, we examine the sensitivity of E. coli to heat-inactivated serum and observed that aerobactin-positive strains survived significantly better than aerobactin-negative strains. The previous results with normal human serum with retained complement activity did not show any correlation with the presence of aerobactin to serum sensitivity. How these results relate to the high incidence of aerobactin-positive strains in bacteremia is not clear, but it is possible that there are sites in the bloodstream where complement may be less active or inactive.
In urinary tract infections in mice, aerobactin-positive strains multiplied more readily in diluted urine than did aerobactin-negative strains. This may reflect the presence of lactoferrin or low iron levels in the urine, further reduced by dilution or diuresis. This increased rate of multiplication in the urine was not reflected in an increase in renal infection. We are unable to show significant differences in renal infection between aerobactin-positive and aerobactin-negative strains, although there was a trend in favor of the aerobactin-positive strains. Further studies will be necessary to examine the relation of aerobactin to urinary tract infection.
